Miho Ushijima

430 total citations
21 papers, 261 citations indexed

About

Miho Ushijima is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Miho Ushijima has authored 21 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Miho Ushijima's work include Prostate Cancer Treatment and Research (11 papers), Hormonal and reproductive studies (6 papers) and Cancer, Lipids, and Metabolism (4 papers). Miho Ushijima is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Hormonal and reproductive studies (6 papers) and Cancer, Lipids, and Metabolism (4 papers). Miho Ushijima collaborates with scholars based in Japan, Australia and United States. Miho Ushijima's co-authors include Yoshinori Fukui, Takehito Uruno, Akira Shiraishi, Masatoshi Eto, Masaki Shiota, Eiji Kashiwagi, Kazuhiko Yamamura, Mayuki Watanabe, Junichi Inokuchi and Daiji Sakata and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Free Radical Biology and Medicine.

In The Last Decade

Miho Ushijima

20 papers receiving 258 citations

Peers

Miho Ushijima

IMMUN

PRM

PHYSI

Yoshikazu Kuboi Japan

Qiancheng Deng China

Yelitza A. R. Rodriguez United States

Christine Pich-Bavastro Switzerland

Da Qian China

Sally A. Nicholas United Kingdom

S. Höxtermann Germany

Jenna D. Lovaas United States

Shoubi Wang China

Maoying Han China

Yoshikazu Kuboi Japan

Miho Ushijima

84 ×0.9

125 ×1.4

IMMUN

34 ×0.6

PRM

13 ×0.4

PHYSI

17 ×0.5

Citations per year, relative to Miho Ushijima Miho Ushijima (= 1×) peers Yoshikazu Kuboi

Countries citing papers authored by Miho Ushijima

Since Specialization

Citations

This map shows the geographic impact of Miho Ushijima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miho Ushijima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miho Ushijima more than expected).

Fields of papers citing papers by Miho Ushijima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miho Ushijima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miho Ushijima. The network helps show where Miho Ushijima may publish in the future.

Co-authorship network of co-authors of Miho Ushijima

This figure shows the co-authorship network connecting the top 25 collaborators of Miho Ushijima. A scholar is included among the top collaborators of Miho Ushijima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miho Ushijima. Miho Ushijima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kashiwagi, Eiji, et al.. (2025). Visfatin Promotes Renal Cell Carcinoma Progression: Evidence from Clinical Samples and Cell Line Models.. PubMed. 12(3). 58–65.

Saito, Yuichi, Akihito Harada, Miho Ushijima, et al.. (2024). Plasma cell differentiation is regulated by the expression of histone variant H3.3. Nature Communications. 15(1). 5004–5004. 3 indexed citations

Shiota, Masaki, Miho Ushijima, Tatsunori Okada, et al.. (2024). Oxidative stress in peroxisomes induced by androgen receptor inhibition through peroxisome proliferator–activated receptor promotes enzalutamide resistance in prostate cancer. Free Radical Biology and Medicine. 221. 81–88. 6 indexed citations

Shiota, Masaki, Miho Ushijima, Leandro Blas, et al.. (2023). NR5A2/HSD3B1 pathway promotes cellular resistance to second-generation antiandrogen darolutamide. Drug Resistance Updates. 70. 100990–100990. 4 indexed citations

Shiota, Masaki, Miho Ushijima, Leandro Blas, et al.. (2022). Correlation between extended pelvic lymph node dissection and urinary incontinence at early phase after robot‐assisted radical prostatectomy. International Journal of Urology. 30(4). 340–346. 5 indexed citations

Ushijima, Miho, Masaki Shiota, Takashi Matsumoto, et al.. (2022). An oral first‐in‐class small molecule RSK inhibitor suppresses AR variants and tumor growth in prostate cancer. Cancer Science. 113(5). 1731–1738. 13 indexed citations

Shiota, Masaki, Naohiro Fujimoto, Takashi Matsumoto, et al.. (2021). Differential Impact of TGFB1 Variation by Metastatic Status in Androgen-Deprivation Therapy for Prostate Cancer. Frontiers in Oncology. 11. 697955–697955. 11 indexed citations

Shiota, Masaki, Naohiro Fujimoto, Yohei Sekino, et al.. (2021). Clinical impact of HSD3B1 polymorphism by metastatic volume and somatic HSD3B1 alterations in advanced prostate cancer. Andrologia. 54(1). e14307–e14307. 5 indexed citations

Kajioka, Shunichi, et al.. (2020). New mouse model of underactive bladder developed by placement of a metal ring around the bladder neck. LUTS Lower Urinary Tract Symptoms. 13(2). 299–307. 1 indexed citations

10.

Shiota, Masaki, Satoshi Endo, Naohiro Fujimoto, et al.. (2020). Polymorphisms in androgen metabolism genes with serum testosterone levels and prognosis in androgen-deprivation therapy. Urologic Oncology Seminars and Original Investigations. 38(11). 849.e11–849.e18. 12 indexed citations

11.

Shiota, Masaki, Yohei Sekino, Fumio Kinoshita, et al.. (2020). Gene amplification of YB‐1 in castration‐resistant prostate cancer in association with aberrant androgen receptor expression. Cancer Science. 112(1). 323–330. 8 indexed citations

12.

Itsumi, Momoe, Masaki Shiota, Yohei Sekino, et al.. (2020). High‐throughput screen identifies 5‐HT receptor as a modulator of AR and a therapeutic target for prostate cancer. The Prostate. 80(11). 885–894. 6 indexed citations

13.

Kashiwagi, Eiji, Fumio Kinoshita, Miho Ushijima, et al.. (2020). The role of adipocytokines and their receptors in bladder cancer: expression of adiponectin or leptin is an independent prognosticator.. PubMed. 12(6). 3033–3045. 9 indexed citations

14.

Shiota, Masaki, Naohiro Fujimoto, Miho Ushijima, et al.. (2019). Genetic Polymorphism in Sex Hormone-binding Globulin With a Prognosis of Androgen Deprivation Therapy in Metastatic Prostate Cancer Among Japanese Men. Clinical Genitourinary Cancer. 17(3). e387–e393. 4 indexed citations

15.

Shiota, Masaki, Naohiro Fujimoto, Miho Ushijima, et al.. (2019). The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese men. Cancer Chemotherapy and Pharmacology. 83(5). 933–938. 4 indexed citations

16.

Sakata, Daiji, Takehito Uruno, Miho Ushijima, et al.. (2019). S100A4 Protein Is Essential for the Development of Mature Microfold Cells in Peyer’s Patches. Cell Reports. 29(9). 2823–2834.e7. 21 indexed citations

17.

Ushijima, Miho, Takehito Uruno, Akihiko Nishikimi, et al.. (2018). The Rac Activator DOCK2 Mediates Plasma Cell Differentiation and IgG Antibody Production. Frontiers in Immunology. 9. 243–243. 18 indexed citations

18.

Uruno, Takehito, Yuki Sugiura, Kazuhiko Yamamura, et al.. (2018). Cholesterol sulfate is a DOCK2 inhibitor that mediates tissue-specific immune evasion in the eye. Science Signaling. 11(541). 32 indexed citations

19.

Yamamura, Kazuhiko, Takehito Uruno, Akira Shiraishi, et al.. (2017). The transcription factor EPAS1 links DOCK8 deficiency to atopic skin inflammation via IL-31 induction. Nature Communications. 8(1). 13946–13946. 63 indexed citations

20.

Shiraishi, Akira, Takehito Uruno, Fumiyuki Sanematsu, et al.. (2016). DOCK8 Protein Regulates Macrophage Migration through Cdc42 Protein Activation and LRAP35a Protein Interaction. Journal of Biological Chemistry. 292(6). 2191–2202. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact